Lo Y M
Department of Chemical Pathology and Institute of Molecular Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region.
Ann N Y Acad Sci. 2001 Sep;945:1-7. doi: 10.1111/j.1749-6632.2001.tb03858.x.
The recent interest in nucleic acids in plasma and serum has opened up numerous new areas of investigation and new possibilities for molecular diagnosis. In oncology, tumor-derived genetic changes, epigenetic alterations, and viral nucleic acids have been found in the plasma/serum of cancer patients. These findings have important implications for the detection, monitoring, and prognostication of many types of malignancies. In prenatal diagnosis, the discovery of fetal DNA in maternal plasma and serum has provided a noninvasive source of fetal genetic material for analysis. This development has important implications for the realization of noninvasive prenatal diagnosis and has provided new methods for the monitoring of pregnancy-associated disorders. Plasma DNA technology has also found recent applications in the fields of organ transplantation, posttrauma monitoring, and infectious agent detection. Future areas of study include circulating RNA in plasma and the elucidation of the biology of release, clearance, and possible functionality of plasma nucleic acids.
近期对血浆和血清中核酸的关注开启了众多新的研究领域以及分子诊断的新可能性。在肿瘤学中,已在癌症患者的血浆/血清中发现肿瘤衍生的基因变化、表观遗传改变及病毒核酸。这些发现对多种恶性肿瘤的检测、监测及预后判断具有重要意义。在产前诊断中,母血血浆和血清中胎儿DNA的发现为分析提供了非侵入性的胎儿遗传物质来源。这一进展对实现非侵入性产前诊断具有重要意义,并为监测妊娠相关疾病提供了新方法。血浆DNA技术近期还在器官移植、创伤后监测及感染因子检测领域得到应用。未来的研究领域包括血浆中的循环RNA以及对血浆核酸释放、清除生物学特性及可能功能的阐释。